The US Food and Drug Administration (FDA) announced that, as of Monday, it will use the term “super intelligence” instead of ...
The complete guide to formulating an effective global regulatory strategy for medical devices, created and curated by experts ...
Regulatory affairs is not a career path you master overnight. Whether you work in medical devices, pharmaceuticals, biologics, combination products, or in vitro diagnostics (IVDs), the learning ...
Office of Translational Sciences (OTS) and the Office of Clinical Pharmacology (OCP) recently released a new manual of ...
A panel of European regulators and industry representatives discussed how to streamline the regulatory process for ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Australia’s Therapeutic Goods Administration (TGA) is considering adding unique device identification (UDI) information to ...
The US Food and Drug Administration (FDA) recently issued warning letters to three manufacturers of active pharmaceutical ...
Commissioner Kyle Diamantas said there is significant public interest in its recently announced Expedited Investigational New ...
A top US Food and Drug Administration (FDA) official stated that the midterm congressional election results will not likely ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, ...
BARCELONA – Experts said that specialized artificial intelligence (AI) tools can be invaluable in helping companies address ...